Synergistic antiviral activity of interferon-α2b and ribavirin against a surrogate virus of hepatitis C.

被引：0
|
作者：
Lau, J [1 ]
Ingravallo, P [1 ]
Skelton, A [1 ]
Hajian, G [1 ]
Zhong, W [1 ]
Hong, Z [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
117
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [1] Interferon-α-2b and ribavirin for retreatment of chronic hepatitis C
    Dettmer, RM
    Reinus, JF
    Clain, DJ
    Aytaman, A
    Levendoglu, H
    Bloom, AA
    Isaacson, MP
    Spinnell, M
    Meyer, D
    Sarabanchong, V
    Zhang, YT
    Garcia-Carrasquillo, RJ
    Markowitz, DD
    Magun, AM
    Worman, HJ
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 758 - 763
  • [2] Antiviral potency analysis and functional comparison of consensus interferon, interferon-α2a and pegylated interferon-α2b against hepatitis C virus infection
    Erickson, Andrea K.
    Seiwert, Scott
    Gale, Michael, Jr.
    ANTIVIRAL THERAPY, 2008, 13 (07) : 851 - 862
  • [3] Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C
    Quinn, Davin
    Kuchler, Elizabeth
    Deming, Paulina
    Arora, Sanjeev
    PSYCHOSOMATICS, 2012, 53 (04) : 400 - 401
  • [4] Xanthohumol enhances antiviral effect of interferon α-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus
    Zhang, Ni.
    Liu, Zhengwen.
    Han, Qunying.
    Chen, Jinghong.
    Lv, Yi.
    PHYTOMEDICINE, 2010, 17 (05) : 310 - 316
  • [5] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [6] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [7] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [8] Response to interferon alfa 2B and ribavirin in Hispanics with hepatitis C.
    Munoz, HJ
    Arroyo, J
    Chinea, B
    Gonzalez, H
    Rodriguez, F
    Toro, D
    Torres, E
    HEPATOLOGY, 2000, 32 (04) : 348A - 348A
  • [9] Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin
    Bruno, S
    Crosignani, A
    Pinzello, GB
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (11) : 922 - 923
  • [10] Synergistic antiviral activity of ribavirin and interferon-α against parrot bornaviruses in avian cells
    Reuter, Antje
    Horie, Masayuki
    Hoeper, Dirk
    Ohnemus, Annette
    Narr, Andreas
    Rinder, Monika
    Beer, Martin
    Staeheli, Peter
    Rubbenstroth, Dennis
    JOURNAL OF GENERAL VIROLOGY, 2016, 97 : 2096 - 2103
12345